Total tau in cerebrospinal fluid detects treatment responders among spinal muscular atrophy types 1–3 patients treated with nusinersen-Reference-Cited by-同舟云学术

Total tau in cerebrospinal fluid detects treatment responders among spinal muscular atrophy types 1–3 patients treated with nusinersen

Published:2022-12-13 Issue: Volume: Page:
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Šimić Goran¹^ORCID,Vukić Vana²,Babić Marija¹,Banović Maria¹,Berečić Ivana¹,Španić Ena¹,Zubčić Klara¹,Golubić Anja Tea³,Barišić Kutija Marija⁴,Merkler Šorgić Ana⁵,Vogrinc Željka⁶,Lehman Ivan²,Hof Patrick R.⁷^ORCID,Sertić Jadranka⁶⁸,Barišić Nina²

Affiliation:

1. Department of Neuroscience, Croatian Institute for Brain Research University of Zagreb School of Medicine Zagreb Croatia

2. Department of Pediatrics University Hospital Centre Zagreb Zagreb Croatia

3. Department of Nuclear Medicine and Radiation Protection University Hospital Centre Zagreb Zagreb Croatia

4. Department of Ophthalmology University Hospital Centre Zagreb Zagreb Croatia

5. Department of Laboratory Diagnostics, Laboratory for Molecular Diagnostics University Hospital Centre Zagreb Zagreb Croatia

6. Department of Laboratory Diagnostics University Hospital Centre Zagreb Zagreb Croatia

7. Nash Family Department of Neuroscience, Friedman Brain Institute, and Ronald M. Loeb Center for Alzheimer's Disease Icahn School of Medicine at Mount Sinai New York New York USA

8. Department of Medical Chemistry and Biochemistry University of Zagreb School of Medicine Zagreb Croatia

Funder

European Regional Development Fund

Hrvatska Zaklada za Znanost

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.14051

Reference60 articles.

1. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy

2. Spinal Muscular Atrophy: The Use of Functional Motor Scales in the Era of Disease-Modifying Treatment

3. Pathogenesis of proximal autosomal recessive spinal muscular atrophy

4. Cerebrospinal fluid phosphorylated tau proteins as predictors of Alzheimer's disease in subjects with mild cognitive impairment;Šimić G;Period Biol,2008

5. Abnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines in cerebrospinal fluid as a prognostic predictor after treatment of nusinersen in SMA patients;Clinical Neurology and Neurosurgery;2024-09

2. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

3. Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen;International Journal of Molecular Sciences;2024-03-29

4. Hippocampus and jejunum biochemical parameters related to physiological ageing of neurons in rats fed diets with copper nanoparticles and different fiber types;Annals of Animal Science;2024-02-07

5. Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review);Neuromuscular Diseases;2023-10-30